The purpose of this study is to examine anhedonia as a potential moderator of treatment
outcomes for Cocaine Use Disorder (CUD). Specifically, this study will investigate how
anhedonia affects outcomes in contingency management (CM) treatment for CUD and whether
anhedonia mediates the effects of adjunctive treatment with a dopaminergic (DAergic) drug,
d-amphetamine, on outcomes in CM for CUD, as well as investigate the contribution of
anhedonia to overall CUD severity.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston University of Illinois at Chicago
Collaborator:
The University of Texas Health Science Center, Houston